World Stroke Organization

Disclaimer:
Information regarding a non-State actor, contained in the section “Non-State Actors Profiles” in the Register, has been provided by that non-State actor itself, and the accuracy and completeness of such information is the sole responsibility of that non-State actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State Actors in Official Relations” has been provided by WHO, subject to certain conditions. All access and use of any section of the Register is governed by the Terms and Conditions of Use.

 Overview

World Stroke Organization
WSO
The World Stroke Organization (WSO) is the world's leading organization in the fight against stroke. It was established in 2006 through a merger of the 3'000 individual members and over 100 society members across the world. WSO's mission is to reduce the global burden of stroke through prevention, treatment and long term care.
http://www.world-stroke.org
14 Nov 2023 02:17:05 PM

 General information

World Stroke Organization
WSO
World Stroke Organization
WSO
The World Stroke Organization (WSO) is the world's leading organization in the fight against stroke. It was established in 2006 through a merger of the 3'000 individual members and over 100 society members across the world. WSO's mission is to reduce the global burden of stroke through prevention, treatment and long term care.
Rue Francois Versonnex 7
Geneva
CH 1207
Switzerland
admin@world-stroke.org
http://www.world-stroke.org

 Governance

Non for profit organization
2006
Board of Directors
Francesca Pezzella
Board Member
Neurologist, Department of Neuroscience, San Camillo Forlanini Hospital, Rome, Italy
Mirjam Heldner
Board Member
Associate Professor for Neurology and Stroke, at the Faculty of Medicine, at the University of Bern, Switzerland
Farah Al Elsa
Board Member
Stroke neurologist at King Fand Specialist Hospital, Saudi Arabia
Philip Bath
Board Member
Stroke Association Professor of Stroke Medicine, University of Nottingham, UK
Caleb Ademola Gbiri
Board Member
Neurophysiotherapist and a Senior Lecturer at Department of Physiotherapy, University of Lagos, Nigeria
Maria Khan Junadi
Board Member
Senior Specialist Neurology. Rashid Hospital, DHA, UA
Luciano Sposato
Board Member
Professor of Neurology and Head of the Stroke Program at the Department of Clinical Neurological Sciences, London Health Sciences Centre (LHSC), Western University, London, ON, Canada.
Epifania Collantes
Board Member
Associate Professor of the Department of Neurosciences, University of the Philippines College of Medicine
David Liebenskind
Board Member
Professor of Neurology at the University of California, Los Angeles
Cheryl Bushnell
Board Member
Professor of neurology and vice chair of research, stroke division chief and co-director of the Neuroscience Clinical Trials and Innovation Center at Wake Forest University School of Medicine
Sean Savitz
Board Member
Director, UTHealth Institute for Stroke and Cerebrovascular Diseases, US
Bruce Ovbiagele
Board Member
Professor, Neurology UCSF Weill Institute for Neurosciencesm US
Patrik Michel
Board Member
Swiss Stroke Society Assoc. Professor. Head of the Laboratory of Clinical Stroke Research Unit, CHUV, Switzerland
Roland Veltkamp
Board Member
German Stroke Society Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany. 2 Department of Neurology, Heidelberg University Hospital, Germany
Gord Gubitz
Board Member
Canadian Stroke Consortium Interim division head; Professor Division of Neurology , Department of Medicine , Faculty of Graduate Studies
Stefan Schwab
Board Member
Neurologist, University of Erlangen, Germany
PN Sylaja
Board Member
Professor and Head of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, India
Keun-Sik Hong
Board Member
Professor of Neurology, Director of Stroke Center, Ilsan Paik Hospital, Inje University
Juliet Bouverie
Board Member
CEO, UK Stroke Association
Lisa Murphy
Board Member
CEO, Stroke Foundation, Australia
Kazu Kitagawa
Board Member
Division of Stroke Research, Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan
Ivy Sebastien
Board Member
Neurologist, St. Stephen’s Hospital, New Delhi
Candice Delcourt
Board Member
Clinical Associate Professor at Macquarie University
Hrvoje Budincevic
Board Member
Central and Eastern European Stroke Society
Atte Meretoja
Board Member
Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland.
Timothy Kleinig
Board Member
Stroke Society of Australasia Professor Department of Neurology, Royal Adelaide Hospital, Adelaide
Thorsten Steiner
Board Member
European Stroke Organisation Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany
Anna Ranta
Board Member
Associate Professor, Department of Medicine, University of Otago, Wellington
Teruyuki Hirano
Board Member
Japan Stroke Society Department of Stroke and Cerebrovascular Medicine, Kyorin University
Arvid Sharma
Board Member
Brain and Heart Foundation Neurophysician at Zydus Hospital Ahmedabad
Rita Krishnamurthi
Board Member
CEO, Stroke Central New Zealand
Yusuke Yakushiji
Board Member
Japan Stroke Association Department of Neurology, Kansai Medical University
Babak Zamani
Board member
Assistant professor of neurology, University of Medical Sciences', Iran
Mayowa Owolabi
Board member
Professor, University of Ibadan, Nigeria
Andrew Lee
Board member
Associate Professor of Stroke and Neurology, Flinders University and Director of Flinders Comprehensive Stroke Centre
Karen Furie
Board member
American Stroke Association Chief of neurology at Rhode Island Hospital, The Miriam Hospital and Bradley Hospital
Arlene Wilkie
Board member
CEO, Stroke Alliance for Europe
Rita Melifonwu
Board member
Founder, Stroke Action Nigeria
Anita Arsovska
Board member
Macedonian organization for a fight against stroke Professor Saints Cyril and Methodius University of Skopje Skopje, North Macedonia
Kazu Toyoda
Board member
Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
The Board of Directors consists of 40 voting members. Board members are elected for a 4-year period. The Board of Directors is responsible for approving the strategic directions of the organization and oversight of all major activities.

Executive Committee
Sheila Martins
President
Neurologist, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brasil
Marc Fisher
Past President
Professor Emeritus, Department of Neurology, University of Massachusetts Medical School, USA
Jeyaraj Pandian
President Elect
Principal and Professor of Neurology Christian Medical College, India
Valeria Caso
Treasurer
Consultant Neurologist, Consultant Neurologist at the Stroke Unit, Santa Maria della Misericordia Hospital University of Perugia
Deidre da Silva
Secretary
Head & Senior Consultant National Neuroscience Institute
Craig Anderson
Vice President
Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney
Michelle Nelson
Vice President SSOs
esearch and Innovation Lunenfeld-Tanenbaum Research Institute; Sinai Health System Investigator; CollaboratorPry for R
Gloria Ekeng
Member at Large representing SSOs
Clinical Nursing Specialist in stroke and TIA, founder of Stroke Care International, Nigeria
Gustavo Saposnik
Member at Large
Associate Professor of Medicine (Neurology) at the University of Toronto, Canada
Hugh Markus
Ex Officio Member
Professor in neurology at the University of Cambridge. Editor in Chief, International Journal of Stroke
The Executive committee consists of a President, Immediate Past-President, 2 Vice-Presidents, Treasurer, Secretary and 3 members at large. The Executive Committee is responsible for the everyday activities of the WSO, which shall have and may exercise the authority of the Board in the management of the business and affairs of the WSO during intervals between meetings.
WSO General Assembly
All active WSO members
A GA is held every every year in conjuction with the World Stroke Congress. All members are invited to the GA. The GA sanction the electronic voting of the members of the Board of Directors and the officers of the Executive Committee.

 Financial information

January
2022
December
2022
1,203,644
September
2023
2,945,809
Private sector entities (including business associations)
Philanthropic foundations
NGOs, academic institutions
Government entities, intergovernmental organizations, including UN
General public, individuals
Total
94,709
36,832
131,541
716,890
716,890
35,000
143,351
178,351
275
275
208,536
208,536
1,020,410
35,000
180,183
1,235,593
Please note that the financial information includes operations of both WSO Switzerland and WSO US. The audit report submitted was only for WSO Switzerland.

 Membership

Individuals
3,431
3,431
NGOs
102
105
Private sector entities
0
0
Philanthropic foundations
0
0
Academic institutions
0
0
Government entities
0
0
Intergovernmental organizations
0
0
http://www.world-stroke.org/membership/wso-member-organizations

Organizational Structure

No data available
No data available

Relations

No data available
WSO Switzerland
Affiliated to
No data available

  Activities

The mission of WSO is to reduce the global burden of stroke through prevention, treatment and long term care. WSO aims to accomplish its mission by: a) Fostering the best standards of practice b) Increasing stroke awareness among the population and among health professionals c) Preventing subtle cerebrovascular disease leading to gait disorders, imbalance, vascular cognitive impairment and behavioural changes d) Influencing policies for stroke prevention and improved health services e) Providing education in collaboration with public and private organizations f) Facilitating stroke research advocacy for people with stroke g) Fostering the development of systems and organisations for long term support of stroke survivors and their families
Strategic Priority 1: One billion more people benefiting from universal health coverage
Strategic Priority 2: One billion more people better protected from health emergencies
Strategic Priority 3: One billion more people enjoying better health and well-being
Strategic Priority 4: More effective and efficient WHO providing better support to countries

  Country presence

Regions
Countries
Activities
Members
Offices / representatives
African Region
Region of the Americas
Eastern Mediterranean Region
European Region
South-East Asia Region
Western Pacific Region
Global

  Disclosure & declaration

Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.

For the purposes of this statement:

  • tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
  • arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.

This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.

In view of the foregoing, please answer the following questions:

  1. Is your entity, or was your entity over the last four years, part of the tobacco or arms industries (as defined above)?
  1. To the best of your entity’s knowledge, is your entity, or has your entity over the last four years, engaged in activities that are aimed at furthering or supporting the interests of the tobacco industry? This includes, but is not limited to, supply contracts, contract work, services and lobbying.
  1. To the best of your entity’s knowledge, does your entity currently, or did your entity over the last four years, have any other association or relationship with the tobacco industry (as defined above). This includes in particular investment interests (other than general mutual funds or similar arrangements whereby your entity has no control over the selection of the investments), commercial business interests, the provision or receipt of financial and/or other support.
  1. If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.

Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.
By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.
WSO receives unrestricted grants from pharmaceutical companies in strict compliance with the WHO regulations for working with the private sector.